secwatch.observer — SEC 8-K summary
======================================

Issuer:     REPLIGEN CORP (RGEN)
CIK:        0000730272
Form:       8-K
Filed at:   2023-10-02T23:59:59+00:00
Accession:  0001193125-23-248189
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Repligen appoints Olivier Loeillot as President and CCO; Hunt remains CEO
-------------------------------------------------------------------------

- Loeillot appointed President and Chief Commercial Officer effective Oct 2, 2023; reports to CEO Tony Hunt.
- Base salary $600k, target bonus 75% of base, signing bonus $1.35M, equity $4M vesting over 5 years.
- Hunt relinquishes President role effective Oct 2 but remains CEO; Loeillot has 20+ yr bioprocess experience from Cytiva/GE and Lonza.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/730272/000119312523248189/0001193125-23-248189-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/730272/000119312523248189/d463559d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-248189

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer